Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 16, 2010Expert Review of Vaccines

Progress in filovirus vaccine development: evaluating the potential for clinical use

View Full Paper
Ask AI
Bookmark
Share

Authors

DFDarryl FalzaranoUniversity of SaskatchewanTGThomas W. GeisbertBoston University
Heinz Feldmann
Heinz FeldmannUniversity of the Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Falzarano et al. (2010) studied this question.

synapsesocial.com/papers/6a75b07e117c5bc884dd79eehttps://doi.org/10.1586/erv.10.152
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Replication-Defective Adenovirus Serotype 5 Vectors Elicit Durable Cellular and Humoral Immune Responses in Nonhuman Primates2005 · 151 citations
  2. 2Effective Post-Exposure Treatment of Ebola Infection2007 · 287 citations
  3. 3Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates2010 · 81 citations
  4. 4Ebola Hemorrhagic Fever, Kikwit, Democratic Republic of the Congo, 1995: Risk Factors for Patients without a Reported Exposure1999 · 134 citations
  5. 5Human papillomavirus vaccines2006 · 106 citations